耐受性
医学
动力外骨骼
不利影响
物理疗法
日常生活活动
外骨骼
物理医学与康复
肺移植
可穿戴计算机
移植
外科
计算机科学
内科学
嵌入式系统
作者
Isabell Anna Just,Denis Fries,Sina Loewe,Volkmar Falk,Nikola Cesarovic,D. Kemper,Frank Edelmann,Anna Feuerstein,Florian L. Haufe,Michele Xiloyannis,Robert Riener,Felix Schoenrath
标识
DOI:10.1080/10400435.2022.2067914
摘要
The aim of this pilot-study was to investigate the safety, feasibility and tolerability of an assisted mobilization of patients with advanced pulmonary diseases, using a lightweight, exoskeleton-type robot (Myosuit, MyoSwiss AG, Zurich, Switzerland). Ten patients performed activities of daily life (ADL) both with and without the device. The mean age was 53.6 (±5.6) years; 70% were male. The assessment of outcome included the evaluation of vital signs, adverse events, rates of perceived exertion and dyspnea (PRE, PRD), the ability to perform ADL and the individual acceptability. Robotic-assisted mobilization was feasible in all patients. No adverse events occurred. RPE and RPD showed no significant difference with or without the Myosuit (mean difference in RPE -1.7, 95%-confidence interval (CI) -1.16, 4.49; p = 0.211; mean difference in RPD 0.00, 95%-CI -1.88, 1.88; p = 0.475). 80% of patients were interested to participate in a robotic-assisted training on a regular basis. A robotic exoskeleton-assisted mobilization is safe, feasible, well-tolerated and well-accepted. The results are highly encouraging to further pursue this highly innovative approach.
科研通智能强力驱动
Strongly Powered by AbleSci AI